Eflornithine (DFMO)

difluoromethylornithine

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Eflornithine (DFMO), covering 2026-01-08 to 2026-02-03. Get the full timeline:

Most recent: Clinical Trial Update: Eflornithine (DFMO) and Etoposide for Relapsed/Refractory Neuroblastoma [Phase 2]